Create new standards of care in neurology, oncology and immunology
Implementation health care reform ( P.L. 111-148 and P.L. 111-152): biosimilar provisions. A bill to prohibit certain patent settlements between brand name drug companies and generic drug companies (S. 369, H.R. 1706).
HCR - Health Issues CPT - Copyright/Patent/Trademark
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
NVG, LLC
1640 Rhode Island Ave. NW, Suite 700, Washington, DC, 20036, US
LISA GERMAN FOSTER ANDREA LARUE